Zevra Therapeutics, Inc. (ZVRA) Total Assets by Year
Zevra Therapeutics, Inc. closed fiscal year 2025 with $284.7M in total assets, $130.1M in total liabilities and $154.7M in shareholder equity. This represents an increase of 59.8% from the prior fiscal year. The table below carries 13 fiscal years, from 2013 to 2025, and the quarters Zevra Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
ZVRA Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $284.7M+59.8% | $178.1M+3.4% | $172.3M+49.4% | $115.3M-13.2% | $132.9M+1086.0% | $11.2M+6.7% | $10.5M-60.7% | $26.7M-49.0% | $52.5M-38.2% | $84.9M+55.5% | $54.6M+298.1% | $13.7M | N/A |
| Total Liabilities | $130.1M-6.1% | $138.5M+25.3% | $110.5M+174.6% | $40.2M+590.7% | $5.8M-92.5% | $77.6M-8.6% | $85.0M-8.9% | $93.3M-15.1% | $110.0M+6.2% | $103.6M+60.1% | $64.7M+4.0% | $62.2M | N/A |
| Total Equity | $154.7M+289.9% | $39.7M-35.9% | $61.9M-17.6% | $75.1M-26.1% | $101.7M+253.1% | -$66.4M+10.8% | -$74.5M-11.9% | -$66.6M-15.7% | -$57.5M-207.6% | -$18.7M-84.7% | -$10.1M+79.1% | -$48.5M-99.9% | -$24.3M |
ZVRA Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $302.7M+18.1% | $278.6M+61.3% | $284.7M+59.8% | $270.1M+41.0% | $256.3M+77.5% | $172.7M+14.2% | $178.1M+3.4% | $191.6M+37.8% | $144.4M+36.9% | $151.3M+41.9% | $172.3M+49.4% | $139.0M+16.3% |
| Total Liabilities | $85.1M-38.8% | $72.8M-44.7% | $130.1M-6.1% | $137.0M+12.5% | $139.0M+24.2% | $131.7M+28.5% | $138.5M+25.3% | $121.8M+70.3% | $111.9M+202.4% | $102.5M+191.2% | $110.5M+174.6% | $71.5M+177.6% |
| Total Equity | $217.7M+85.7% | $205.8M+401.7% | $154.7M+289.9% | $133.2M+90.9% | $117.2M+261.0% | $41.0M-16.0% | $39.7M-35.9% | $69.8M+13.4% | $32.5M-44.8% | $48.8M-17.6% | $61.9M-17.6% | $61.5M-34.4% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Zevra Therapeutics, Inc. financials
Frequently Asked Questions
What was Zevra Therapeutics, Inc.'s total assets in fiscal year 2025?
Zevra Therapeutics, Inc. closed fiscal year 2025 with $284.7M in total assets, $130.1M in total liabilities and $154.7M in shareholder equity.
How fast is Zevra Therapeutics, Inc.'s total assets growing?
Zevra Therapeutics, Inc. (ZVRA) total assets rose by 59.8% year over year, from $178.1M to $284.7M in fiscal year 2025.
What was Zevra Therapeutics, Inc.'s total assets in the most recent quarter?
Zevra Therapeutics, Inc. (ZVRA) reported $302.7M in total assets in Q2 2026. This represents an increase of 18.1% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Zevra Therapeutics, Inc. (ZVRA) reported on that line in every period on record.